United States · FDA National Drug Code directory
Clindamycin phosphate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43066-993_b31a3e6c-9d61-4038-be8b-6e2ca0f6ca0b
- Product NDC
- 43066-993
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Clindamycin phosphate
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170628
- Source listing expiry
- 20271231
Source-listed ingredients
- CLINDAMYCIN PHOSPHATE — 600 mg/50mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BAG in 1 CASE (43066-993-24) / 50 mL in 1 BAG · 43066-993-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →